February 15, 2007

The American public remains uncomfortable with animal cloning, but many food animal veterinarians consider cloning to be just another reproductive technology.


With some 430 attendees, the 2007 annual AVMA Veterinary Leadership Conference was the highest attended VLC to date. Held Jan. 5-7 in Chicago, the meeting was divided into an Informational Assembly and Special Session for the AVMA House of Delegates, and a leadership development program.


Dr. Douglas G. Corey spent many summers in his youth driving a wheat combine, hauling hay, building fences, and performing many other chores required on his family's wheat and cattle ranch in Pendleton, Ore.

Global Issues

Experts meet in Africa to discuss avian influenza Printer-friendly version Representatives from countries around the globe gathered in Africa this past December for the Fourth International Conference on Avian Influenza. The African Union and the Government of Mali, in conjunction with the European Union, hosted the event. Highly pathogenic avian influenza was first detected in Africa in February 2006. According to the African Union/Interafrican Bureau for Animal Resources, eight African countries have reported the virus, with 95 percent of the outbreaks occurring in Egypt and Nigeria. Reportedly, at least 10 people have died in Egypt from the disease. The goal of the conference was to assess programs to counter the threat of avian and pand ...


Federal requirements for drug pedigrees do not affect veterinarians Printer-friendly version Veterinarians do not need to keep drug pedigrees under federal requirements that the Food and Drug Administration began enforcing in December 2006. A drug pedigree is a statement of origin that identifies each prior sale, purchase, or trade of a drug—including the date of those transactions and the names and addresses of all parties to them. The Prescription Drug Marketing Act of 1987 and Prescription Drug Amendments of 1992 established requirements relating to the wholesale distribution of human prescription drugs. A primary purpose of the PDMA was to increase safeguards to prevent the introduction and retail sale of substandard, ineffective, and c ...